Tuesday, February 25, 2020

OU-OUHSC Symposium registration and poster submission open now

Abstract submission for the Fourth Annual OU-OUHSC IBEST Symposium is open!!!

Graduates and undergraduates from all STEM majors with an interest in medical technology fields are encouraged to submit an abstract research poster to the annual poster competition. The top three winners will bring home cash prizes! Please remember to register for the event prior to submitting an abstract.


The symposium is aimed to bring together the science and engineering community from the OU Norman campus and the clinicians and scientists from the OU Health Sciences Center campus. Through engaging clinicians, entrepreneurs, basic scientists, engineers, and key players from the bioscience industry, the OU Institute for Biomedical Engineering, Science, and Technology (IBEST) is committed to building new partnerships and spreading awareness. Leadership of the symposium includes members of both campuses, including clinical input to ensure a welcoming and enabling environment for clinicians to attend. High-level presentations and focused research talks will both showcase the exciting new capabilities and State-wide developments in the areas of biomedical engineering and healthcare



Tuesday, January 28, 2020

SBME Director travels to France with Norman mayor

Stephenson School of Biomedical Engineering Director, Dr. Michael Detamore, recently traveled to Clermont-Ferrand, France with Mayor Breea Clark to celebrate Norman’s 25-year anniversary with our sister city. 

Dr. Detamore served as one of ten delegates representing Norman, and participated in meetings, tours, and visits with the group while in France.  

Friday, January 24, 2020

BME student selected for prestigious grant

Gokhan Gunay, a graduate Biomedical Engineering student at the University of Oklahoma, was recently selected as a recipient of a Sigma Xi Grant.

The Sigma Xi Grants in Aid of Research (GIAR) program encourages close working relationships between students and mentors and promotes scientific excellence and achievement through hands-on learning. The program is highly competitive, only granting funding to 12%-15% of applicants. 

Ovarian cancer is the most lethal gynecological cancer, with a 47% survival rate within 5 years. Gunay and his team, under the supervision of Dr. Handan Acar, are researching techniques for specific drug delivery to small tumors by developing models in the lab and engineering polymer-based nanoparticles to target the tumors and deliver anti-cancer drugs. The Sigma Xi grant will fund the materials used for the formation of spheroid models and for preparation of nanoparticles. 


Pictured is the Ovarian cancer spheroids produced in the Acar lab.